(Q35063647)

6 August 2017

1 reference

title

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology (English)

1 reference

6 August 2017

1 reference

adult oligodendroglioma

1 reference

1

Guido Reifenberger

1 reference

6 August 2017

David N Louis

2

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Journal of Neuropathology & Experimental Neurology

6 August 2017

published in

1 reference

6 August 2017

volume

62

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

111-126

1 reference

Successful chemotherapy for recurrent malignant oligodendroglioma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Successful chemotherapy for newly diagnosed aggressive oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Current treatment of oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Chemotherapy for the treatment of oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

New perspectives for the diagnosis and treatment of oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

OLIG-1 and 2 gene expression and oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

OLIG2 as a specific marker of oligodendroglial tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Influence of unrecognized molecular heterogeneity on randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Mutation analysis of the p73 gene in nonastrocytic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Transcriptional inactivation of TP73 expression in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

p73: Friend or foe in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

A transcript map of the chromosome 19q-arm glioma tumor suppressor region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Epigenetic silencing of PEG3 gene expression in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Peg3/Pw1 is a mediator between p53 and Bax in DNA damage-induced neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

PTEN mutations in gliomas and glioneuronal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Subtyping of oligo-astrocytic tumours by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Clonality of oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

CpG island methylator phenotypes in aging and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Towards a novel classification of human malignancies based on gene expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Microarrays as cancer keys: an array of possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Oligodendroglioma: the Rotterdam-Dijkzigt experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Glioma classification: a molecular reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Mitotic recombination of chromosome 17 in astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F62.2.111

21 January 2018

Identifiers

DOI

10.1093/JNEN/62.2.111

1 reference

6 August 2017

1 reference